Ni Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ni Li has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Jun Qin
Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China; Jinfeng Laboratory, Chongqing 401329, China
5 shared publications Guanghong Gong
4 shared publications- Qintong Li
Departments of Obstetrics & Gynecology and Pediatrics, Cancer Center, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Sichuan University, Chengdu, China
4 shared publications - Guohong Hu
Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
3 shared publications - Xiaoming Wang
Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases, Nanjing Medical University, Nanjing, China
3 shared publications Guoying Zhang
Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China
2 shared publications
Latest Publications
- Top Cited Papers
- 24 April 2025
- Published by Elsevier in Cancer Cell
- Vol. 43 (7) , 1261-1278.e10
KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy
- 24 April 2025
- Published by Elsevier in Cancer Cell
- Vol. 43 (7) , 1261-1278.e10
Top Cited PapersKMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy
- Top Cited PapersOpen Access
- 26 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-20
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
Chronic inflammation and an immunosuppressive microenvironment promote prostate cancer (PCa) progression and diminish the response to immune checkpoint blockade (ICB) therapies. However, it remains unclear how and to what extent these two events are coordinated. Here, we show that ARID1A, a subunit of the SWI/SNF chromatin remodeling complex, functions downstream of inflammation-induced IKKβ activation to shape the immunosuppressive tumor microenvironment (TME). Prostate-specific deletion ofArid1acooperates withPtenloss to accelerate prostate tumorigenesis. We identify polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) as the major infiltrating immune cell type that causes immune evasion and reveal that neutralization of PMN-MDSCs restricts the progression ofArid1a-deficient tumors. Mechanistically, inflammatory cues activate IKKβ to phosphorylate ARID1A, leading to its degradation via β-TRCP. ARID1A downregulation in turn silences the enhancer ofA20deubiquitinase, a critical negative regulator of NF-κB signaling, and thereby unleashes CXCR2 ligand-mediated MDSC chemotaxis. Importantly, our results support the therapeutic strategy of anti-NF-κB antibody or targeting CXCR2 combined with ICB for advanced PCa. Together, our findings highlight that the IKKβ/ARID1A/NF-κB feedback axis integrates inflammation and immunosuppression to promote PCa progression.
- 26 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-20
Top Cited PapersOpen AccessARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
Chronic inflammation and an immunosuppressive microenvironment promote prostate cancer (PCa) progression and diminish the response to immune checkpoint blockade (ICB) therapies. However, it remains unclear how and to what extent these two events are coordinated. Here, we show that ARID1A, a subunit of the SWI/SNF chromatin remodeling complex, functions downstream of inflammation-induced IKKβ activation to shape the immunosuppressive tumor microenvironment (TME). Prostate-specific deletion ofArid1acooperates withPtenloss to accelerate prostate tumorigenesis. We identify polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) as the major infiltrating immune cell type that causes immune evasion and reveal that neutralization of PMN-MDSCs restricts the progression ofArid1a-deficient tumors. Mechanistically, inflammatory cues activate IKKβ to phosphorylate ARID1A, leading to its degradation via β-TRCP. ARID1A downregulation in turn silences the enhancer ofA20deubiquitinase, a critical negative regulator of NF-κB signaling, and thereby unleashes CXCR2 ligand-mediated MDSC chemotaxis. Importantly, our results support the therapeutic strategy of anti-NF-κB antibody or targeting CXCR2 combined with ICB for advanced PCa. Together, our findings highlight that the IKKβ/ARID1A/NF-κB feedback axis integrates inflammation and immunosuppression to promote PCa progression.
- Open Access
- 15 April 2022
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (8)
Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ–stimulated antitumor immunity
IFN-γ–stimulated MHC class I (MHC-I) antigen presentation underlies the core of antitumor immunity. However, sustained IFN-γ signaling also enhances the programmed death ligand 1 (PD-L1) checkpoint pathway to dampen antitumor immunity. It remains unclear how these opposing effects of IFN-γ are regulated. Here, we report that loss of the histone dimethyltransferase WHSC1 impaired the antitumor effect of IFN-γ signaling by transcriptional downregulation of the MHC-I machinery without affecting PD-L1 expression in colorectal cancer (CRC) cells. Whsc1 loss promoted tumorigenesis via a non-cell-autonomous mechanism in an Apcmin/+ mouse model, CRC organoids, and xenografts. Mechanistically, we found that the IFN-γ/STAT1 signaling axis stimulated WHSC1 expression and, in turn, that WHSC1 directly interacted with NLRC5 to promote MHC-I gene expression, but not that of PD-L1. Concordantly, silencing Whsc1 diminished MHC-I levels, impaired antitumor immunity, and blunted the effect of immune checkpoint blockade. Patient cohort analysis revealed that WHSC1 expression positively correlated with enhanced MHC-I expression, tumor-infiltrating T cells, and favorable disease outcomes. Together, our findings establish a tumor-suppressive function of WHSC1 that relays IFN-γ signaling to promote antigen presentation on CRC cells and provide a rationale for boosting WHSC1 activity in immunotherapy.
- 15 April 2022
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (8)
Open AccessHistone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ–stimulated antitumor immunity
IFN-γ–stimulated MHC class I (MHC-I) antigen presentation underlies the core of antitumor immunity. However, sustained IFN-γ signaling also enhances the programmed death ligand 1 (PD-L1) checkpoint pathway to dampen antitumor immunity. It remains unclear how these opposing effects of IFN-γ are regulated. Here, we report that loss of the histone dimethyltransferase WHSC1 impaired the antitumor effect of IFN-γ signaling by transcriptional downregulation of the MHC-I machinery without affecting PD-L1 expression in colorectal cancer (CRC) cells. Whsc1 loss promoted tumorigenesis via a non-cell-autonomous mechanism in an Apcmin/+ mouse model, CRC organoids, and xenografts. Mechanistically, we found that the IFN-γ/STAT1 signaling axis stimulated WHSC1 expression and, in turn, that WHSC1 directly interacted with NLRC5 to promote MHC-I gene expression, but not that of PD-L1. Concordantly, silencing Whsc1 diminished MHC-I levels, impaired antitumor immunity, and blunted the effect of immune checkpoint blockade. Patient cohort analysis revealed that WHSC1 expression positively correlated with enhanced MHC-I expression, tumor-infiltrating T cells, and favorable disease outcomes. Together, our findings establish a tumor-suppressive function of WHSC1 that relays IFN-γ signaling to promote antigen presentation on CRC cells and provide a rationale for boosting WHSC1 activity in immunotherapy.
- 1 October 2017
- Published by Elsevier in Optics Communications
- Vol. 401, 11-17
Depth compensating calculation method of computer-generated holograms using symmetry and similarity of zone plates
- 1 October 2017
- Published by Elsevier in Optics Communications
- Vol. 401, 11-17
Depth compensating calculation method of computer-generated holograms using symmetry and similarity of zone plates
- Open Access
- 21 August 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (9) , 3375-3391
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
The histone H3K36 methyltransferase SETD2 is frequently mutated or deleted in a variety of human tumors. Nevertheless, the role of SETD2 loss in oncogenesis remains largely undefined. Here, we found that SETD2 counteracts Wnt signaling and its inactivation promotes intestinal tumorigenesis in mouse models of colorectal cancer (CRC). SETD2 was not required for intestinal homeostasis under steady state; however, upon irradiation, genetic inactivation of Setd2 in mouse intestinal epithelium facilitated the self-renewal of intestinal stem/progenitor cells as well as tissue regeneration. Furthermore, depletion of SETD2 enhanced the susceptibility to tumorigenesis in the context of dysregulated Wnt signaling. Mechanistic characterizations indicated that SETD2 downregulation affects the alternative splicing of a subset of genes implicated in tumorigenesis. Importantly, we uncovered that SETD2 ablation reduces intron retention of dishevelled segment polarity protein 2 (DVL2) pre-mRNA, which would otherwise be degraded by nonsense-mediated decay, thereby augmenting Wnt signaling. The signaling cascades mediated by SETD2 were further substantiated by a CRC patient cohort analysis. Together, our studies highlight SETD2 as an integral regulator of Wnt signaling through epigenetic regulation of RNA processing during tissue regeneration and tumorigenesis.
- 21 August 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (9) , 3375-3391
Open AccessHistone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
The histone H3K36 methyltransferase SETD2 is frequently mutated or deleted in a variety of human tumors. Nevertheless, the role of SETD2 loss in oncogenesis remains largely undefined. Here, we found that SETD2 counteracts Wnt signaling and its inactivation promotes intestinal tumorigenesis in mouse models of colorectal cancer (CRC). SETD2 was not required for intestinal homeostasis under steady state; however, upon irradiation, genetic inactivation of Setd2 in mouse intestinal epithelium facilitated the self-renewal of intestinal stem/progenitor cells as well as tissue regeneration. Furthermore, depletion of SETD2 enhanced the susceptibility to tumorigenesis in the context of dysregulated Wnt signaling. Mechanistic characterizations indicated that SETD2 downregulation affects the alternative splicing of a subset of genes implicated in tumorigenesis. Importantly, we uncovered that SETD2 ablation reduces intron retention of dishevelled segment polarity protein 2 (DVL2) pre-mRNA, which would otherwise be degraded by nonsense-mediated decay, thereby augmenting Wnt signaling. The signaling cascades mediated by SETD2 were further substantiated by a CRC patient cohort analysis. Together, our studies highlight SETD2 as an integral regulator of Wnt signaling through epigenetic regulation of RNA processing during tissue regeneration and tumorigenesis.
- Open Access
- 20 March 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (4) , 1284-1302
AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis
Loss of phosphatase and tensin homolog (PTEN) and activation of the PI3K/AKT signaling pathway are hallmarks of prostate cancer (PCa). However, these alterations alone are insufficient for cells to acquire metastatic traits. Here, we have shown that the histone dimethyl transferase WHSC1 critically drives indolent PTEN-null tumors to become metastatic PCa. In a PTEN-null murine PCa model, WHSC1 overexpression in prostate epithelium cooperated with Pten deletion to produce a metastasis-prone tumor. Conversely, genetic ablation of Whsc1 prevented tumor progression in PTEN-null mice. Molecular characterization revealed that increased AKT activity due to PTEN loss directly phosphorylates WHSC1 at S172, preventing WHSC1 degradation by CRL4Cdt2 E3 ligase. Increased WHSC1 expression transcriptionally upregulates expression of RICTOR, a pivotal component of mTOR complex 2 (mTORC2), to further enhance AKT activity. Therefore, the AKT/WHSC1/mTORC2 signaling cascade represents a vicious feedback loop that elicits unrestrained AKT signaling. Furthermore, we determined that WHSC1 positively regulates Rac1 transcription to increase tumor cell motility. The biological importance of a WHSC1-mediated signaling cascade is substantiated by patient sample analysis in which WHSC1 signaling is tightly correlated with disease progression and recurrence. Taken together, our findings highlight a pivotal link between an epigenetic regulator, WHSC1, and key intracellular signaling molecules, AKT, RICTOR, and Rac1, to drive PCa metastasis.
- 20 March 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (4) , 1284-1302
Open AccessAKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis
Loss of phosphatase and tensin homolog (PTEN) and activation of the PI3K/AKT signaling pathway are hallmarks of prostate cancer (PCa). However, these alterations alone are insufficient for cells to acquire metastatic traits. Here, we have shown that the histone dimethyl transferase WHSC1 critically drives indolent PTEN-null tumors to become metastatic PCa. In a PTEN-null murine PCa model, WHSC1 overexpression in prostate epithelium cooperated with Pten deletion to produce a metastasis-prone tumor. Conversely, genetic ablation of Whsc1 prevented tumor progression in PTEN-null mice. Molecular characterization revealed that increased AKT activity due to PTEN loss directly phosphorylates WHSC1 at S172, preventing WHSC1 degradation by CRL4Cdt2 E3 ligase. Increased WHSC1 expression transcriptionally upregulates expression of RICTOR, a pivotal component of mTOR complex 2 (mTORC2), to further enhance AKT activity. Therefore, the AKT/WHSC1/mTORC2 signaling cascade represents a vicious feedback loop that elicits unrestrained AKT signaling. Furthermore, we determined that WHSC1 positively regulates Rac1 transcription to increase tumor cell motility. The biological importance of a WHSC1-mediated signaling cascade is substantiated by patient sample analysis in which WHSC1 signaling is tightly correlated with disease progression and recurrence. Taken together, our findings highlight a pivotal link between an epigenetic regulator, WHSC1, and key intracellular signaling molecules, AKT, RICTOR, and Rac1, to drive PCa metastasis.
- 1 July 2016
- Published by Elsevier in Infrared Physics & Technology
- Vol. 77, 153-161
A simulation method of aircraft plumes for real-time imaging
- 1 July 2016
- Published by Elsevier in Infrared Physics & Technology
- Vol. 77, 153-161
A simulation method of aircraft plumes for real-time imaging
- 1 July 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 1, 177-180
Realization of Parallel Ant Colony Algorithm Based on TBB Multi-core Platform
TBB (Thread Building Blocking) is currently a representative parallel computing platform of multi-core processors. The ant colony algorithm is used to solve combinatorial optimization problem of discrete-time systems. With the expansion of the problem scale, it often results in rapid increase of calculation. Based on TBB a parallel ant colony algorithm was researched and developed to improve the efficiency of the algorithm. TBB parallel multi-core technology and implementation techniques of the parallel ant colony algorithm based on TBB are introduced in detail. This algorithm was applied to resolve large-scale TSP (traveling salesman problem). Experiment results showed that the parallel optimization progress is flexible to operate and multi-core resources can be made full use of to greatly improve algorithm efficiency. And it provided possibility for real-time calculation of large-scale combinatorial optimization engineering problems.
- 1 July 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 1, 177-180
Realization of Parallel Ant Colony Algorithm Based on TBB Multi-core Platform
TBB (Thread Building Blocking) is currently a representative parallel computing platform of multi-core processors. The ant colony algorithm is used to solve combinatorial optimization problem of discrete-time systems. With the expansion of the problem scale, it often results in rapid increase of calculation. Based on TBB a parallel ant colony algorithm was researched and developed to improve the efficiency of the algorithm. TBB parallel multi-core technology and implementation techniques of the parallel ant colony algorithm based on TBB are introduced in detail. This algorithm was applied to resolve large-scale TSP (traveling salesman problem). Experiment results showed that the parallel optimization progress is flexible to operate and multi-core resources can be made full use of to greatly improve algorithm efficiency. And it provided possibility for real-time calculation of large-scale combinatorial optimization engineering problems.
- 1 January 2009
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 1, 94-98
Scene Matching Algorithm Evaluation Based on Multi-core Parallel Computing Technology
Application of multi-core parallel computing technology in modeling and simulation field can promote effective schedule of multi-core computing resources. A scene matching simulation platform was built to evaluate computation efficiency of different algorithm implementation schemes. Users can select different preprocessing and matching algorithms from algorithm library and configure different algorithm parameters. Two kinds of typical multi-core computing technologies, which are OpenMP and TBB, are applied here to realize different algorithms. Simulation experiment results show that computing resources can be used more effectively and simulation efficiency of the evaluation platform can be greatly improved.
- 1 January 2009
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 1, 94-98
Scene Matching Algorithm Evaluation Based on Multi-core Parallel Computing Technology
Application of multi-core parallel computing technology in modeling and simulation field can promote effective schedule of multi-core computing resources. A scene matching simulation platform was built to evaluate computation efficiency of different algorithm implementation schemes. Users can select different preprocessing and matching algorithms from algorithm library and configure different algorithm parameters. Two kinds of typical multi-core computing technologies, which are OpenMP and TBB, are applied here to realize different algorithms. Simulation experiment results show that computing resources can be used more effectively and simulation efficiency of the evaluation platform can be greatly improved.
- 1 October 2008
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 211-217
Research on Pervasive simulation based on grid and pervasive computing technology
Pervasive simulation technology integrates and applies the pervasive computing technology, grid technology, distributed interactive simulation technology and Web technology to provide a simulation supporting platform. The pervasive simulation architecture can be built to encapsulate different simulation resources as services so that they can be shared and reused in WAN. It can support the access of simulation resources through the Web browser of intelligent terminals and facilitates. And the dynamical assembly and fast construction of the complex simulation systems can also be supported. In this paper, the pervasive simulation architecture based on grid and pervasive computing technology was brought forward and the six involved key technologies to construct the architecture were also researched and discussed in detail.
- 1 October 2008
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 211-217
Research on Pervasive simulation based on grid and pervasive computing technology
Pervasive simulation technology integrates and applies the pervasive computing technology, grid technology, distributed interactive simulation technology and Web technology to provide a simulation supporting platform. The pervasive simulation architecture can be built to encapsulate different simulation resources as services so that they can be shared and reused in WAN. It can support the access of simulation resources through the Web browser of intelligent terminals and facilitates. And the dynamical assembly and fast construction of the complex simulation systems can also be supported. In this paper, the pervasive simulation architecture based on grid and pervasive computing technology was brought forward and the six involved key technologies to construct the architecture were also researched and discussed in detail.